- In September 2022, Olympus Corporation, a leading manufacturer specializing in optical and digital precision technology, revealed the launch of VISERA ELITE III. This latest surgical visualization platform is designed to meet the needs of healthcare professionals (HCPs) for endoscopic procedures across various medical disciplines, including gynecology
- In July 2022, GE Healthcare, a prominent innovator in global medical technology, pharmaceutical diagnostics, and digital solutions, introduced its most advanced ultrasound system to date, the next-generation Voluson Expert 22. This new addition to GE Healthcare’s award-winning Women’s Health portfolio employs graphic-based beam former technology, resulting in higher-quality images and enhanced flexibility in imaging capabilities
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Minilaparotomy, Laparoscopy, and Hysteroscopy), Method (Minimally Invasive and Less Invasive), Usage (Disposable and Reusable), End User (Hospitals, Specialty Clinics, and Others) – Industry Trends and Forecast to 2031
.
The Global Female Sterilization Devices Market size was valued at USD 5.97 USD Billion in 2023.
The Global Female Sterilization Devices Market is projected to grow at a CAGR of 5.56% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
